NANCY TOMPKINS: Open Payments
NPI 1922554146 · POPLAR BLUFF, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,343 in 40 payments from 10 companies in 2025. Trend: 2023 $8,606 · 2024 $6,213 · 2025 $8,343
Speaker / faculty: $7,800Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 14 | $7,800 |
| Corcept Therapeutics | 9 | $192 |
| Sequel Med Tech, LLC | 3 | $111 |
| Dexcom, Inc. | 3 | $50 |
| Abbott Laboratories | 2 | $47 |
| Madrigal Pharmaceuticals | 1 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $31 |
| Novo Nordisk Inc | 1 | $23 |
| Tandem Diabetes Care, Inc. | 3 | $22 |
Products named: OMNIPOD, Korlym, TWIIST, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, REZDIFFRA, GEMTESA, MOUNJARO.
Industry payments across MO — which companies pay providers there.
